|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124,000.00 KRW | -0.56% |
|
-2.21% | -0.64% |
| Nov. 26 | Medy-Tox Inc. authorizes a Buyback Plan. | CI |
| Nov. 26 | Medy-Tox Inc. announces an Equity Buyback for 24,916 shares. | CI |
| Capitalization | 870B 591M 504M 470M 442M 815M 53.33B 887M 5.47B 2.13B 25.21B 2.22B 2.17B 92.17B | P/E ratio 2025 * |
28.6x | P/E ratio 2026 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise value | 900M 611K 521K 486K 457K 843K 55.15M 917K 5.66M 2.2M 26.07M 2.29M 2.25M 95.32M | EV / Sales 2025 * |
3.57x | EV / Sales 2026 * | 3.03x |
| Free-Float |
73.82% | Yield 2025 * |
0.89% | Yield 2026 * | 0.9% |
| 1 day | -0.56% | ||
| 1 week | -2.21% | ||
| Current month | -0.48% | ||
| 1 month | +0.24% | ||
| 3 months | +1.72% | ||
| 6 months | -25.70% | ||
| Current year | -0.64% |
| 1 week | 121,000 |  | 127,100 |
| 1 month | 119,800 | | 129,700 |
| Current year | 112,100 | | 182,700 |
| 1 year | 112,100 | | 182,700 |
| 3 years | 112,100 | | 316,500 |
| 5 years | 94,952.38 | | 316,500 |
| 10 years | 87,333.98 | | 700,091.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hee-Seok Joo
PRN | Corporate Officer/Principal | 59 | 2020-03-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Hee-Seok Joo
BRD | Director/Board Member | 59 | 2020-03-26 |
Do-Hyeon Jeong
BRD | Director/Board Member | 51 | 2023-03-28 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.56% | -2.21% | -9.82% | -0.61% | 595M | |
| +2.84% | +3.20% | -4.07% | -0.43% | 74.51B | |
| +0.98% | -2.70% | -35.41% | -39.44% | 58.22B | |
| -0.62% | +0.38% | +33.43% | +235.89% | 53.6B | |
| +0.24% | +66.90% | +66.90% | +66.90% | 52.43B | |
| -2.84% | -4.56% | +10.35% | -39.55% | 26.05B | |
| +0.98% | -5.32% | +32.59% | +16.71% | 18.68B | |
| +0.18% | -8.88% | +119.27% | +159.38% | 18.39B | |
| -0.66% | -13.12% | +42.61% | +1,004.75% | 16.61B | |
| -0.04% | -.--% | +58.67% | +154.72% | 14.02B | |
| Average | +0.05% | -1.75% | +31.45% | +155.83% | 33.31B | |
| Weighted average by Cap. | +0.56% | -0.58% | +22.60% | +104.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 252B 171M 146M 136M 128M 236M 15.43B 257M 1.58B 616M 7.29B 642M 628M 26.66B | 296B 201M 171M 160M 150M 277M 18.12B 301M 1.86B 723M 8.56B 754M 738M 31.31B |
| Net income | 31.05B 21.08M 17.98M 16.77M 15.77M 29.06M 1.9B 31.64M 195M 75.92M 899M 79.15M 77.44M 3.29B | 48.78B 33.12M 28.25M 26.34M 24.78M 45.66M 2.99B 49.71M 307M 119M 1.41B 124M 122M 5.17B |
| Net Debt | 29.74B 20.19M 17.22M 16.06M 15.11M 27.84M 1.82B 30.31M 187M 72.72M 861M 75.81M 74.18M 3.15B | 25.16B 17.08M 14.57M 13.58M 12.78M 23.55M 1.54B 25.63M 158M 61.51M 728M 64.13M 62.74M 2.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-11 | 124,000.00 ₩ | -0.56% | 41,898 |
| 25-12-10 | 124,700.00 ₩ | -1.42% | 15,009 |
| 25-12-09 | 126,500.00 ₩ | +2.60% | 34,026 |
| 25-12-08 | 123,300.00 ₩ | -2.99% | 29,505 |
| 25-12-05 | 127,100.00 ₩ | +0.39% | 21,140 |
End-of-day quote Korea S.E., December 10, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A086900 Stock
Select your edition
All financial news and data tailored to specific country editions
